Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 258-027-0 | CAS number: 52587-68-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
FAT 21095/C was found to be sensitizer to skin (contact allergenic) in albino guinea pigs.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1994
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Version / remarks:
- 92/69/EEC, B.6.
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Data from a reliable in vivo test conducted before the enforcement of Commission Regulation (EU) 640/2012 of 06 July 2012 amending, for the purpose of its adaptation to technical progress, Regulation (EC) No. 440/2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) are available.
- Specific details on test material used for the study:
- Test article: FAT 21095/C
Batch No.: 34
Additional specification: Lanacron Brown S-BRL crude moist lab dried
Contents/ Purity: ca.80 %
Physical properties: solid
Storage conditions: room temperature
Validity: July, 1999
Test article received: April 13, 1994 - Species:
- guinea pig
- Strain:
- other: Pirbright White strain (Tif: DHP)
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
-Source: CIBA-GEIGY Limited, Animal Production 4332 Stein / Switzerland
- Housing:The animals were housed individually in Macrolon cages (Type 3), assigned to the different groups by means of random numbers generated by the random number generator, identified by individual ear tags.
- Diet (e.g. ad libitum):The animals received ad libitum standard guinea pig pellets - NAFAG No. 845, Gossau SG.
- Water (e.g. ad libitum):fresh water ad libitum.
- Acclimation date: August 17, 1994.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 30 to 70
- Photoperiod (hrs dark / hrs light): 12 hours light cycle day. - Route:
- intradermal
- Vehicle:
- physiological saline
- Concentration / amount:
- 5%
- Day(s)/duration:
- 0
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
- Route:
- epicutaneous, occlusive
- Vehicle:
- physiological saline
- Concentration / amount:
- 50%
- Day(s)/duration:
- 8
- Adequacy of induction:
- highest technically applicable concentration used
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- physiological saline
- Concentration / amount:
- 1%
- Day(s)/duration:
- 21
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 5 per sex for the test group and 5 of one sex for controls.
After the challenge procedure, it was not possible to conclude if the test substance is a sensitiser or not and therefore testing in additional animals was performed to give a toal of 20 test and 10 control animals. - Details on study design:
- Test procedure and concentrations used.
PRETEST
INTRADERMAL INDUCTION:
The concentration for the intradermal injections was selected on account of the solubility of the test article in standard vehicles and its local and systemic tolerability in a pretest. The following concentration of test article has been used for intradermal injection:
5 % in physiological saline (w/v). Since 5 % FAT 21095/C in physiological saline could be injected and was well tolerated, this concentration was used for the intradermal induction.
Epidermal Applications (induction and challenge)
The concentrations for the epidermal applications were selected on account of the primary irritation potential of the test article. The following concentrations of FAT 21095/C have been examined on separate animals for the determination of the maximum subirritant concentration. 1, 5, 10, 20, 30, and 50% in physiological saline. 50 % was the highest possible concentration of the test article in physiological saline.
TEST PROCEDURE:
DAY 0: Induction, intradermal injections.
Three pairs of intradermal injections (0.1 ml per injection) were made simultaneously into the left and right side of the shaved neck of the test and control group animals.
Test group:
- adjuvant/saline mixture 1:1 (v/v)
- 5 % FAT 21095/C in physiological saline (w/v)
- 5 % FAT 21095/C in the adjuvant/saline mixture (w/v)
Control group:
- adjuvant/saline mixture 1:1 (v/v)
- adjuvant/saline mixture 1:1 (v/v)
- physiological saline
DAY 8: INDUCTION, epidermal application
In the test group FAT 21095/C was incorporated in physiological saline and applied on a filterpaper patch to the neck of the animals (patch 2x4 cm; approx. 0.4 g per patch; occluded administration for 48 hours). The control group was treated with the vehicle only.
Test group:
- 50 % FAT 21095/C in physiological saline
Control group:
- physiological saline only
DAY 21: Challenge
The test and control group animals were tested on one flank with FAT 21095/C in physiological saline and on the other flank with the vehicle alone (patch 2x2 cm; approx. 0.2 g per patch; occluded administration for 24 hours).
Test and control group:
- 1 % FAT 21095/C in physiological saline
- physiological saline only - Challenge controls:
- Challenge
The test and control group animals were tested on one flank with FAT 21095/C in physiological saline and on the other flank with the vehicle alone (patch 2x2 cm; approx. 0.2 g per patch; occluded administration for 24 hours).
Test and control group:
- 1 % FAT 21095/C in physiological saline
- physiological saline only - Positive control substance(s):
- yes
- Remarks:
- 2-Mercaptobenzothiazole puriss.
- Positive control results:
- In test group, 20/20animals were affected after 24 hours and 48 hours.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- Intradermal induction - 5 %, Epicutaneous induction - 50 % and Epicutaneous challenge - 1 %
- No. with + reactions:
- 7
- Total no. in group:
- 20
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- Intradermal induction - 5 %, Epicutaneous induction - 50 % and Epicutaneous challenge - 1 %
- No. with + reactions:
- 8
- Total no. in group:
- 20
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- Intradermal induction - 5% in olive oil, Epidermal induction - 50% in vaseline, Epidermal challenge - 30% in vaseline.
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- Intradermal induction - 5% in olive oil, Epidermal induction - 50% in vaseline, Epidermal challenge - 30% in vaseline.
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Remarks on result:
- positive indication of skin sensitisation
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- According to the EEC classification criteria (Commission Directive 93/21/EEC, April 27, 1993) FAT 21095/C did show skin-sensitising (contact allergenic) potential in albino guinea pigs.
- Executive summary:
A GLP-compliant study was performed to determine the skin sensitisation potential of FAT 21095/C according to the OECD Guideline No. 406, adopted May 12, 1981, adapted July 17, 1992, by the OECD council, and on Annex V, Part B of Council Directive 67/548/EEC (Commission Directive 92/69/EEC of July 31, 1992). A total of 20 test and 10 control animals (guinea pigs) were used to perform the experiment. Based on the findings of the pretest, 5 % and 50 % of FAT 21095/C was used as intradermal (Day 0) and epidermal induction (Day 8) respectively. 1 % of FAT 21095/C in physiological saline was used for challenge. Under the experimental conditions employed, 35 % and 40 % of the animals of the test group showed skin reactions 24 and 48 hours after removing the dressings, respectively. FAT 21095/C is, therefore, classified as a moderate sensitiser in albino guinea pigs according to the grading of Magnusson and Kligman. According to CLP-criteria a test article is classified as a sensitiser in the case where a positive response is noted in at least 30 % of the animals. Hence, according to the CLP-Regulation FAT 21095/C was found to be sensitizer to skin (contact allergenic) in albino guinea pigs.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
A GLP-compliant key study was performed to determine the skin sensitisation potential of FAT 21095/C according to the OECD Guideline No. 406, adopted May 12, 1981, adapted July 17, 1992, by the OECD council, and on Annex V, Part B of Council Directive 67/548/EEC (Commission Directive 92/69/EEC of July 31, 1992). A total of 20 test and 10 control animals (guinea pigs) were used to perform the experiment. Based on the findings of the pretest, 5 % and 50 % of FAT 21095/C was used as intradermal (Day 0) and epidermal induction (Day 8) respectively. 1 % of FAT 21095/C in physiological saline was used for challenge. Under the experimental conditions employed, 35 % and 40 % of the animals of the test group showed skin reactions 24 and 48 hours after removing the dressings, respectively. FAT 21095/C is, therefore, classified as a moderate sensitiser in albino guinea pigs according to the grading of Magnusson and Kligman. Hence, according to the CLP classification criteria FAT 21095/C was found to be sensitizer to skin (contact allergenic) in albino guinea pigs.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
According to the GHS classification criteria FAT 20077/C did show a skin-sensitising (contact allergenic) potential in albino guinea pigs.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.